Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Rituximab to Mycophenolate Mofetil in Pemphigus Vulgaris has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus Vulgaris

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pemphigus Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2020-01-18